U.S. FDA Approves Weight Loss Pill from Novo Nordisk
The U.S. Food and Drug Administration approves a weight loss pill from Novo Nordisk, therefore giving the Danish drugmaker an edge in the race...
U.S. FDA Approves Bispecific Lunsumio VELO™ by Roche
Roche has made an announcement that the US Food and Drug Administration (FDA) has provided approval for CD20xCD3 bispecific Lunsumio VELO™-mosunetuzumab as a subcutaneous...
Boehringer Ingelheim Moves to Lower Costs for Medicines in the U.S.
Boehringer Ingelheim, which is a 140-year-old family-owned biopharmaceutical company and the one that has made a commitment to enhancing human as well as animal...
Samsung Biologics Acquires GSK’s Human Genome Sciences Site in U.S.
Samsung Biologics has agreed to acquire 100% of Human Genome Sciences from GSK, a move that secures the company’s first U.S.-based biologics manufacturing site...
Cytokinetics Secures First FDA Approval With Myqorzo Heart Drug
Cytokinetics has reached a defining milestone after the U.S. Food and Drug Administration approved its heart drug Myqorzo for adults with obstructive hypertrophic cardiomyopathy,...
Thermo Fisher launches Alzheimers Disease Registry
Thermo Fisher Scientific Inc., which is regarded as the world leader when it comes to serving science, went on to announce the enrollment of...
Meiji Seika Pharma, MBC BioLabs Drug Discovery Partnership
Meiji Seika Pharma has entered into a strategic collaboration with MBC BioLabs to deepen its global drug discovery innovation partnership and strengthen external research...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...